During the past decade, Universitaets-Kinderklinik Heidelberg conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitaets-Kinderklinik Heidelberg" #1 sponsor was "German CLL Study Group" with 4 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored, "European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma" with 1 trials sponsored and "Ludwig-Maximilians - University of Munich" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaets-Kinderklinik Heidelberg" #1 collaborator was "ALL SCTped Forum" with 1 trials as a collaborator, "ALL-BFM Study Group" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Australian & New Zealand Children's Haematology/Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Universitaets-Kinderklinik Heidelberg" are "Chronic Lymphocytic Leukemia" (3 trials), "Cystic Fibrosis" (3 trials), "Leukemia" (3 trials), "Neuroblastoma" (3 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Universitaets-Kinderklinik Heidelberg" in a lesser frequency.

Most popular intervention types in "Universitaets-Kinderklinik Heidelberg" are "Drug" (14 trials), "Radiation" (9 trials), "Biological" (8 trials), "Procedure" (7 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (7 trials), "cyclophosphamide" (6 trials), "filgrastim" (5 trials), "ifosfamide" (5 trials) and "melphalan" (5 trials). Other intervention names were less common.

The vast majority of trials in "Universitaets-Kinderklinik Heidelberg" are 18 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universitaets-Kinderklinik Heidelberg". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Universitaets-Kinderklinik Heidelberg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitaets-Kinderklinik Heidelberg, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".